Anirvan Ghosh - 03 Nov 2022 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Executive Officer, Director
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Anirvan Ghosh
Issuer symbol
UBX
Transactions as of
03 Nov 2022
Transactions value $
-$2,638
Form type
4
Filing time
04 Nov 2022, 16:49:23 UTC
Previous filing
15 Sep 2022
Next filing
21 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Sale -$2.64K -1.1K -1.12% $2.40 97.2K 03 Nov 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units which vest over time measured from the grant date.
F3 Reflects a 1-for-10 reverse stock split of the Issuer's common stock, effected by the Issuer on October 19, 2022, which was exempt from reporting pursuant to Rule 16a-9.